Activity Objectives:

What's New with Hypertension: How Low to Go, New Evidence, Consensus Recommendations, and Treating Resistant Hypertension is organized by University Learning Systems (ULS) and will be held from Jan 27, 2018 - Jan 27, 2021. This Conference has been approved for a maximum of 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.

Target Audience:
• Physicians
• Canadian Physicians
• Physician Assistants
• Nurse Practitioners
• Nurses
• Pharmacists


This course provides five (5) hours of AMA Category 2 credit.

American Osteopathic Association (AOA): This course provides five (5) hours of AMA Category 2 credit.

Canadian Physicians:
Members of the College of Family Physicians of Canada CFPC : This course provides five (5) hours of AMA Category 2 credit.

Physician Assistants:
American Academy of Physician Assistants (AAPA): This course provides five (5) hours of AMA Category 2 credit.

At the conclusion of this session, the participant will be able to:
• Review medications and lifestyle modifications that are recommended for the treatment of hypertension.
• Compare and contrast guidelines and consensus recommendations for the treatment of patients with hypertension.
• Identify patient specific blood pressure goals for patients with hypertension.
• Interpret findings from the SPRINT trial and identify strengths and weaknesses of these data when applies to determining a patient-specific BP goal.
• Identify appropriate and patient specific antihypertensive agents for the treatment of hypertension based on age, gender, and comorbid diseases.
• Describe recommended drug therapy for patients with hypertension with and without compelling indications.
• Recommend appropriate combination drug therapy for the treatment of hypertension.
• Describe risks of certain combination antihypertensive drug therapies.
• Define resistant hypertension and recommend appropriate treatment options.
• Design patient-centered antihypertensive treatment plans in complex patients with hypertension.
Additional details will be posted as soon as they are available.

Intended Audience

Renal Medicine Disease and Hypertension

Activity Payment Details

Activity Fee : USD $19.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


University Learning Systems (ULS)

View Organizer Details